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Why and How We Should Avoid  
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A B S T R A C T
A large body of evidence has emerged recently about the harmful effects of chronic 
right ventricular (RV) apical pacing on left ventricular (LV) function leading to an 
increase in morbidity and mortality. Right ventricular apical pacing is unphysiologic 
because it produces aberrant LV depolarization, and in turn mechanical LV dyssyn-
chrony with resultant long-term unfavorable hemodynamic and structural changes. Al-
though the data about RV pacing-induced LV dysfunction outlined in this discussion 
are persuasive, its clinical applicability in pacemaker practice remains challenging. 
The ongoing transition to new pacing sites will succeed only with major technologic 
improvements in lead implantation. Meanwhile, pacing algorithms minimizing right 
ventricular pacing might be preferable at least in patients with sick sinus syndrome or 
non-permanent atrioventricular block.
I N T R O D U C T I O N
A large body of evidence has emerged recently about the harmful effects of chronic 
right ventricular (RV) pacing (mostly apical) on left ventricular (LV) function.1-8 The 
findings in several important trials correlate with the abnormalities in LV function 
previously documented in experimental animals subjected to RV pacing.9-13 RV pac-
ing is unphysiologic because it produces aberrant LV depolarization, and in turn 
mechanical LV dyssynchrony with resultant long-term unfavorable hemodynamic 
(abnormal systolic and diastolic function) and structural changes. Faced with proof 
that RV apical pacing causes an increase in morbidity and mortality, the question 
arises as to whether we should continue pacing the apical RV as the preferred site or 
consider alternative sites to minimize LV dysfunction. Although the data about RV 
pacing-induced LV dysfunction outlined in this discussion are persuasive its clinical 
applicability in pacemaker practice remains challenging.
D AV I D  T R I A L
The DAVID trial compared the clinical effectiveness of dual chamber implantable 
cardioverter defibrillators (ICDs) programmed to the DDDR pacing mode at 70 ppm 
vs the VVI mode at 40 ppm.2 The atrioventricular (AV) delay was programmed ac-
cording to the clinical judgment of the investigators and was commonly set at 180 ms 
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thereby favoring ventricular pacing in the majority of patients. 
The study revealed a strong trend toward higher mortality and 
hospitalization for new or worsened congestive heart failure 
(CHF) in the DDDR group (with nearly 60% of ventricular 
beats being paced). The DAVID study suggested that un-
necessary RV apical pacing delivered as part of the DDDR 
arm produced ventricular desynchronization with impaired 
LV hemodynamic performance that was ultimately harmful. 
The VVI group fared better because the programmed rate of 
40 ppm minimized RV apical pacing (with 1% of ventricular 
beats being paced). The depression of LV function by RV api-
cal pacing may be more important in ICD patients with poor 
LV function and/or a prior history of heart failure.
M A D I T  I I  T R I A L
In the MADIT II study (in which programming of the ICDs 
was not standardized), the development of new or worsened 
CHF was more common in the ICD arm (19.9%) compared 
with the conventional-treatment patients (14.9%).4 The higher 
incidence of CHF in the ICD group was in all likelihood due 
to ventricular desynchronization rather than myocardial injury 
from ICD shocks. Steinberg et al5 presented a subanalysis of 
the MADIT II trial at the 2003 Annual NASPE meeting and 
subsequently published in 2005,5a indicating that the harmful 
effects of RV pacing were correlated with the percentage of 
ventricular pacing confirming the findings of the MOST Trial 
discussed below.
M O S T  T R I A L
The MOST study demonstrated an association between 
the percentage of RV pacing in the DDDR mode (with main-
tenance of AV synchrony) and CHF in patients with sick sinus 
syndrome and QRS <120 ms.3 The harmful consequences of 
RV pacing in the MOST trial appeared related to nonphysi-
ologic LV contraction. A cumulative % of ventricular pacing 
index <10% was associated with the lower rates of CHF hos-
pitalizations and an index >90% was associated with higher 
rates of hospitalization for CHF. For DDDR pacing, the risk 
of CHF increased linearly until the aforementioned % index 
reached 60% and then it formed a plateau. The MOST study 
also found a correlation between the cumulative % of ven-
tricular pacing index and the development of atrial fibrillation 
(AF) presumably induced by LV dysfunction.
T H E  D A N I S H  A A I R  V S .  D D D R  T R I A L
Andersen et al1 have reported the results of the first 
randomized trial comparing the AAIR and DDDR modes 
of pacing in 117 consecutive patients who received a first 
pacemaker for sick sinus syndrome. Patients were followed 
for 2.9±1.1 years and had normal AV conduction (accord-
ing to previously used arbitrary criteria by these workers), 
and no bundle branch block. The primary endpoints were 
changes from baseline to last follow-up in left atrial (LA) size 
and left ventricular (LV) function determined by M-mode 
echocardiography. The patients were randomized to three 
arms: AAIR, DDDR-s (short rate-adaptive AV delay- 110-150 
ms) and DDDR-l (fixed long AV delay ≥250 ms) modes. The 
AV delay was not optimized because the study was designed 
to evaluate the effect of cumulative right ventricular pacing. 
The AAIR group exhibited no significant change in the LA 
and LV diameters and LV fractional shortening. However, the 
LA diameter increased significantly in both DDDR groups 
(more marked in the DDDR-s group), while left ventricular 
fractional shortening decreased significantly in the DDDR-s 
group but not in the DDDR-l group.
The AAIR vs. DDDR trial clearly documents the detri-
mental effects of ventricular desynchronization or LV dyssyn-
chrony produced by long-term unphysiologic RV apical pac-
ing.1 The DDDR-s group with 90% proportion of RV pacing 
developed LA dilatation and decreased fractional shortening 
but the DDDR-l group with 17% proportion of RV pacing 
developed LA dilatation but no change in fractional shorten-
ing. Atrial fibrillation (which was diagnosed on the basis of a 
12-lead ECG at planned follow-up visits) was more common 
in the DDDR group indicating that ventricular desynchroniza-
tion promotes AF probably by causing LA dilatation.
C O M PA R I S O N  O F  T H E  D A N I S H  A A I R  V S .  D D D R 
T R I A L  W I T H  V V I ( R )  V S .  D D D ( R )  T R I A L S
The lack of LV desynchronization in the AAI mode may 
explain the remarkable benefit of AAI compared with VVI 
pacing obtained by the Danish Group in patients with the sick 
sinus syndrome in a protocol where the investigation focused 
only on the role of AV synchrony.14 In contrast, studies com-
paring the DDD(R) with the VVI(R) modes of pacing have 
yielded less impressive and somewhat inconsistent results 
probably because the benefit of AV synchrony was attenuated 
by the depressant effect of LV desynchronization in patients 
using the DDD(R) mode.15-18
The results of AAIR vs. DDDR study are in accordance 
with the data from the DAVID and MOST trials where the 
endpoint was hospitalization for CHF though sequential LV 
function was not evaluated in these two trials.2,3
R I G H T  V E N T R I C U L A R  PA C I N G  
I N  Y O U N G  PA T I E N T S
The harmful long-term effects of RV apical pacing have 
also been documented in children and young patients with 
congenital heart block.7,8 A study involving long-term fol-
low-up (up to 19 years) of children with congenital AV block 
and no structural congenital cardiac defects and RV apical 
pacing demonstrated evidence of global LV dysfunction when 
compared with size-matched control patients.7 Another study 
from Bordeaux, France confirmed these findings by compar-
ing echocardiographic data obtained before and after pace-
maker implantation.8 Twenty-one patients with complete AV 
62
HOSPITAL CHRONICLES 3(2), 2008
block with RV apical pacing were followed for 8 ± 3 years and 
matched with healthy controls. The pacemaker patients dis-
played statistically significant asymmetric LV hypertrophy, LV 
dilatation, impairment of LV function compared to findings 
before pacemaker implantation and those of the controls.
M I T R A L  R E G U R G I T A T I O N  I N D U C E D  
B Y  V E N T R I C U L A R  D E S Y N C H R O N I Z A T I O N
LV desynchronization as with left bundle branch block 
or RV pacing may cause varying degrees of mitral regur-
gitation that aggravate the hemodynamic status in patients 
with dilated cardiomyopathy (idiopathic or ischemic). Left 
ventricular contraction initiated by apical RV pacing alters 
papillary muscle function with resultant derangement of the 
time sequence of activation of the mitral valve apparatus. The 
marked improvement of mitral regurgitation after cardiac 
resynchronization for standard indications (poor systolic LV 
function and LV dyssynchrony) is well-known.19-22 Patients 
with previously implanted RV pacemakers who undergo ven-
tricular resynchronization also exhibit acute and long-term 
improvement in mitral regurgitation.20,23,24 However, some 
patients with a normal LV ejection (but with dysynchrony) 
and RV pacemaker-induced severe mitral regurgitation and 
CHF may derive marked symptomatic improvement and 
can be spared mitral valve replacement by the institution of 
biventricular pacing.25-27
A R E  T H E  A B N O R M A L I T I E S  I N D U C E D  
B Y  L O N G -T E R M  V E N T R I C U L A R 
D E S Y N C H R O N I Z A T I O N  R E V E R S I B L E ?
Chronic unphysiologic or RV pacing in dogs induces 
adverse cellular changes with myofibrillar disarray, asym-
metric myocardial hypertrophy, LV dilatation and biochemical 
changes.9-13 The reversibility of these changes has not been 
studied.
In man, RV pacing produces reversible alterations in lo-
cal myocardial blood flow that are more pronounced during 
pacing the RV apex than the outflow tract.28,29 In this regard, 
Nielsen et al29 found reversible alterations in regional myo-
cardial blood flow upon switching temporarily from chronic 
RV apical pacing to the AAI mode suggesting that perfusion 
defects are related to the altered pattern of ventricular depo-
larization. Thus, alterations in blood flow seem to reflect the 
changes in ventricular depolarization and may not have an 
important long-term detrimental impact on LV function.
In their myocardial blood flow study, Nielsen et al29 
programmed their DDD patients (the same as those in the 
DDDR-s group) to the AAI mode at the time of myocardial 
blood flow measurement. The LV ejection fraction measured 
during temporary AAI pacing was significantly higher than 
during DDD-s pacing and not different from the LV ejection 
fraction measured at the time of implantation about 22 months 
previously. In patients with systolic CHF and an implanted RV 
pacemaker programmed with an optimal AV delay, cardiac 
resynchronization produces an immediate improvement in LV 
function and functional mitral regurgitation on the basis of a 
more coordinated LV contraction. On a long-term basis, there 
is evidence that such patients exhibit further improvement of 
LV function because of reverse remodeling suggesting some 
reversibility of LV dysfunction. These observations are in 
keeping with the observation that the mechanical left atrial 
(LA) remodeling caused by long-term VVI pacing is reversible 
upon the establishment of DDD pacing.30
Much more work is needed to determine the reversibility 
of the LA and LV abnormalities engendered by ventricular 
desynchronization in patients with a variety of heart disease 
and LV function.
I F  R V  PA C I N G  I S  P O T E N T I A L LY  H A R M F U L , 
H O W  S H O U L D  W E  C H A N G E  O U R  P R A C T I C E ?
1. Do not pace if it is not necessary
This applies especially to ICD patients without sick sinus 
syndrome or AV block based on the results of the David trial.31 
The VVI or DDI pacing mode (with a long AV delay) at a rate 
of 40 ppm may be appropriate for many patients to prevent 
unnecessary RV pacing.
2. Alternative single-site RV pacing
Pooled data from many studies suggest that RV outflow (or 
septal) pacing provides somewhat better acute hemodynamic 
performance than RV apical pacing.32 An acute improvement 
does not necessarily translate into long-term improvement in 
LV function. At present, long-term studies have shown mixed 
results in terms of LV function using RV pacing sites other 
than the RV apex.33-41 The study of Tse et al28 that compared 
RV outflow tract pacing vs. RV apical pacing in a small number 
of patients (with dual chamber pacemaker, optimal AV delay 
and >95% ventricular pacing) revealed a significant drop in 
LV ejection fraction only in the patients with RV apical pacing 
after 18 months (the longest follow-up of all the chronic stud-
ies). These findings should be confirmed in a larger number 
of patients with longer follow-up. The long-term studies of 
alternative site RV pacing are difficult to interpret because of 
the small number of patients, wide range of LV function, spec-
trum of underlying heart disease, lack of standardization of the 
RV pacing site, % ventricular pacing, different endpoints, and 
varying durations of follow-up mostly too short.42 At present 
it seems premature to abandon the RV apical site in the hope 
of preserving LV function and further standardized extensive 
multicenter studies involving large cohorts are needed to 
explore the role of alternative RV pacing sites.43,44
3. Bifocal RV pacing
There is no evidence that dual-site RV pacing is superior 
to single-site pacing in the acute setting or in follow-up stud-
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ies of a few months.45-49 However some workers now advocate 
dual-site RV pacing as an alternative to biventricular pacing 
in patients in whom LV pacing is not feasible but there is as 
yet no convincing evidence that this approach is worthwhile. 
However, preliminary results suggest that the addition of a 
second RV lead may be beneficial in patients with severe 
CHF refractory to traditional biventricular pacing (triple 
ventricular pacing).50
4. AAI and AAIR pacing
The AAI and AAIR modes represent the only sure way of 
preventing RV-induced deterioration of LV function by pro-
moting normal ventricular depolarization. The development 
of spontaneous complete heart block during AAI pacing in 
carefully selected patients is unusual but it is associated with 
syncope in about half the cases.51-55 In the USA, single lead 
atrial pacing is rarely used for fear of litigation because its 
occurrence no matter how infrequent, is difficult to accept 
considering that the fundamental purpose of antibradycardia 
pacing is to prevent it. In Europe AAI and AAIR modes are 
considered viable and acceptable in carefully screened patients 
with sick sinus syndrome without bundle branch block and 
long PR interval.56,57
5. His Bundle Pacing
The most ambitious attempt to maintain LV synchrony and 
LV function is through His bundle pacing.58 This technique 
is in its infancy, technically demanding and can only be con-
sidered in patients without intraventricular conduction delay. 
The current role of this modality is presently unclear.
6. Ablate and Pace patients with atrial fibrillation. The 
PAVE Trial
The PAVE trial is the first prospective, randomized study 
to evaluate biventricular pacing (BVP) in patients with AF who 
underwent AV junctional ablation and received a permanent 
pacemaker.59-61 Enrollment criteria included the presence of 
chronic AF for at least 1 month, New York Heart Association 
class I, II, or III, and inability to walk more than 450 meters 
during the 6-minute hall walk test. All patients were on a stable 
cardiovascular drug regimen. PAVE patients were enrolled 
regardless of their LV function.
A total of 252 patients were randomized in a 2:1 fashion 
to either ablation plus RV pacing (n=106) or ablation plus 
biventricular pacing (n=146). The primary endpoint was 
exercise capacity as measured by the 6-minute hall walk test, 
with secondary endpoints of functional capacity as measured 
by peak VO2, exercise duration, and quality-of-life score. Biv-
entricular device implantation was unsuccessful in 21 patients, 
vs 0 unsuccessful RV pacing implants. The final population of 
patients eligible for analysis included 102 RV pacing patients 
and 82 biventricular pacing patients. There was no significant 
difference in baseline clinical characteristics between the 2 
groups. After 3 months, patients in the RV pacing group began 
to experience a marked decline in exercise capacity, whereas 
patients in the biventricular pacing group maintained their 
functional status. The difference between the groups at 6 
months (82 m vs. 56 m, a difference of 26 m) was statistically 
significant (P =0.03).59,60
Measurements of LV ejection fraction (LVEF) revealed a 
significant decline in RV pacing patients.61 LVEF in the RV 
pacing group dropped from 44.9% at the pre-implant time 
point to 40.7% at 6 months, while LVEF in the biventricular 
pacing group was stable over the follow-up period. The LVEF 
difference between the groups at 6 months (46.0% vs. 40.7%) 
was statistically significant (P =0.03). A full analysis of the 
various subgroups is not yet available except for the study of 
Daoud et al who stratified the patients into LVEF ≤35% (21 
RV, 21 biventricular pacing), and LVEF >35% (36 RV, 51 
biventricular pacing). After 6 months, the improvement in the 
6 minute walk was the same in both the RV and biventricular 
pacing groups starting with LVEF 35%. In contrast in the 
group with LVEF ≤35%, RV patients improved less while 
biventricular pacing patients improved more (p=0.07). In 
addition more patients with biventricular pacing improved 
in distance walked while more RV patients worsened (p 
<0.04).
The PAVE trial thus revealed that biventricular pacing 
provides a significant, meaningful improvement in functional 
capacity over RV pacing in patients with chronic AF after 
AV nodal ablation with a sustained benefit in the group with 
LV ejection ≤35%. On this basis it seems reasonable at this 
juncture to recommend biventricular pacing in “ablate and 
pace” patients with LVEF ≤35% and wait for further data 
before considering biventricular pacing in the group with 
better LV function.
6. The best of both worlds
a. Old algorithms
Theoretically in patients with normal AV conduction, 
functional AAIR pacing should occur with virtual elimina-
tion of ventricular pacing by using the DDDR mode with a 
long AV delay (250-300 ms). The AAIR vs. DDDR Danish 
trial showed this was not possible at least with an AV delay 
of 250 ms (17% RV pacing), confirming data from a small 
number of studies that used AV delays as long as 300 ms or 
AV search hysteresis.1,62-67 The causes of the 17% incidence of 
ventricular pacing in the DDDR-l group in the Danish trial 
was not studied and may have involved many mechanisms such 
as ventricular fusion, pseudofusion beats etc.1
b. Minimal RV pacing
In 1997 Andersen68 an obvious proponent of AAI pacing 
wrote that “in the future, another technical solution may be 
available with modern units, i.e., automatic mode switching 
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from AAI to DDD…” for patients with sick sinus syndrome. 
Such devices are now available and their performance in 
minimizing RV pacing has been demonstrated but their long-
term impact on LV function remains to be proven.69,70 With 
such new devices we will be able to give patients without AV 
block or bundle branch block, the best of both worlds: almost 
continuous physiologic ventricular depolarization through the 
His-Purkinje-system without the risk of AV block.
C O N C L U S I O N
The results of the AAIR vs. DDDR, DAVID , MADIT II, 
MOST and PAVE trials should be considered a wake-up call to 
avoid RV pacing if possible and to investigate the use ventricu-
lar resynchronization (biventricular pacing or monochamber 
LV pacing) not only for treatment of existing LV dyssynchrony 
in patients with congestive heart failure and left bundle branch 
block, but for “primary prevention” in the first place in selected 
patients (especially those with LVEF ≤35%) who require ven-
tricular pacing most of the time.6 The pacemaker landscape 
and “the way we do business” may change dramatically in the 
next few years. It is possible that univentricular RV pacing may 
be relegated to a far lesser role and replaced by biventricular 
or monochamber LV pacing71 as more data emerges about its 
potentially deleterious effect on LV function. We are likely to 
see a growth of triple ventricular pacing (2RV and 1 LV or 1RV 
and 2 LV) or even more complicated pacing arrangements.50,72 
The move towards improved pacing modalities is particularly 
important in children with or without congenital cardiac de-
fects in view of the long duration of pacing throughout life.73 
The ongoing transition to new pacing sites will succeed only 
with major technologic improvements in lead implantation.74-83 
Meanwhile, pacing algorithms minimizing ventricular pacing 
in patients with sinus node dysfunction or intermittent AV 
block might be preferable.75,81
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